• Response to the Editor

• Ohta Hiroaki

• Uenishi Kazuhiro, Shiraki Masataka

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 60 ~ 61

• Letter to the Editor

• Park Yoo-Kyoung

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 59 ~ 59

• Associations between serum 25-hydroxyvitamin D3 level and skeletal muscle mass and lower limb muscle...

• Kuwabara Akiko

• Tsugawa Naoko, Kondo Hiroshi, Ao Misora, Fujiwara Hitomi, Hosokawa Natsuki, Matsumoto Shiho,&nb...

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 53 ~ 58

• Bone turnover rate and bone formation/resorption balance during the early stage after switching from...

• Nakatoh Shinichi

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 45 ~ 52

• Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in ...

• Tanaka Mizue

• Nakamura Yukio, Itoh Soichiro, Kato Yoshiharu

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 37 ~ 44

• Favorable effects of skeletal muscle on bone are distinguished according to gender and skeletal site...

• Kim Kyoung-Min

• Lee Eun-Young, Lim Soo, Jang Hak-Chul, Kim Chang-Oh

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 32 ~ 36

• Osteoporosis prevention and osteoporosis exercise in community-based public health programs

• Nguyen Vu H.

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 18 ~ 31

• Denosumab for the treatment of osteoporosis

• McClung Michael R.

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 8 ~ 17

• An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosi...

• Yeap Swan Sim

• Hew Fen Lee, Damodaran Premitha, Chee Winnie, Lee Joon Kiong, Goh Emily Man Lee, Chan Siew Phen...

• Osteoporosis and Sarcopenia   2017  Volume.3  No.1 1 ~ 7